Business
Media
Conferences
Publications
CME/CE
Resources
Subscribe

Opinion|Videos|May 1, 2024

A Growing Incidence of Renal Masses

Neal Shore, MD, FACS, and Brian M. Shuch, MD, introduce themselves and discuss the growing incidence of kidney cancer, the general prognosis, and early signs and symptoms.

Episodes in this series

Video 1 - "A Growing Incidence of Renal Masses"

EP. 1 A Growing Incidence of Renal Masses

Video 2 - "Diagnostic Tests for Kidney Cancer"

EP. 2 Diagnostic Tests for Kidney Cancer

EP. 3 Limitations of Conventional Imaging for Assessing Renal Masses

EP. 3 Limitations of Conventional Imaging for Assessing Renal Masses

Video 4 - "The Role of a Multidisciplinary Team in Managing Kidney Cancer"

EP. 4 The Role of a Multidisciplinary Team in Managing Kidney Cancer

Neal Shore, MD, FACS, and Brian M. Shuch, MD, experts on kidney cancer

EP. 5 Staging and Treatment Decisions for Kidney Cancer

Neal Shore, MD, FACS, and Brian M. Shuch, MD, experts on kidney cancer

EP. 6 Advances in Imaging for Kidney Cancer Diagnosis and Management

Neal Shore, MD, FACS, and Brian M. Shuch, MD, experts on kidney cancer

EP. 7 Overview of Clinical Trials for New Imaging Options for Kidney Cancer

Neal Shore, MD, FACS, and Brian M. Shuch, MD, experts on kidney cancer

EP. 8 Potential Impact of PET/CT Imaging on Improving Patient Care

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Latest CME

Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment

Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment

Jason Hafron, MD; Aaron D. Berger, MD; Arpeet Shah, MD

Radioligand Therapy 101: The Science Behind the Strategy

Radioligand Therapy 101: The Science Behind the Strategy

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

BURST CME™ Resource Center: Integrating Novel PSMA-Directed Radioligand Approaches for Diagnosis and Management of Prostate Cancer

BURST CME™ Resource Center: Integrating Novel PSMA-Directed Radioligand Approaches for Diagnosis and Management of Prostate Cancer

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Nerina McDonald, MSPAS, PA-C; Scott T. Tagawa, MD, MS, FACP, FASCO

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Ready for Radioligand Therapy? Patient Selection and Sequencing Simplified

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Community Practice Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies

Jeremie Calais, MD, PhD; Scott T. Tagawa, MD, MS, FACP, FASCO

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies

Ana Kiess, MD, PhD; Erin Grady, MD, CCD, FACNM, FSNMMI; Himanshu Nagar, MD, MS; Scott T. Tagawa, MD, MS, FASCO, FACP

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Trending on Urology Times

The UroOnc Minute: AUA 2026 Update on Prostate Cancer Early Detection, With Badrinath R. Konety, MBBS

FDA approves enfortumab vedotin plus pembrolizumab for MIBC

Daniel George, MD, on the significance of the capivasertib approval for PTEN-deficient prostate cancer

Amy E. Krambeck, MD, on choosing between CVAC and FANS for suction-based ureteroscopy

Study suggests tamsulosin deprescribing may be appropriate for select men with BPH